Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact

被引:0
|
作者
Ledo, Susana [1 ]
Leite, Angela [4 ]
Souto, Teresa [2 ]
Pimenta Dinis, Maria Alzira [3 ]
Sequeiros, Jorge [1 ]
机构
[1] Univ Porto, Oporto, Portugal
[2] Lusophone Univ Oporto, Oporto, Portugal
[3] UFP, UFP Energy Environm & Hlth Res Unit FP ENAS, Oporto, Portugal
[4] Univ Europeia, Lisbon, Portugal
关键词
Pre-symptomatic testing; psychological impact; late-onset genetic diseases; FAMILIAL AMYLOID POLYNEUROPATHY; MACHADO-JOSEPH-DISEASE; HUNTINGTON-DISEASE; PSYCHOLOGICAL-ASPECTS; PREDICTORS; QUALITY; LIFE;
D O I
10.7334/psicothema2016.298
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background: Over the past 20 years, studies have revealed that the communication of a pre-symptomatic test (PST) result for late-onset diseases, such as Huntington's disease (HD), doesn't cause psychological disturbance. This cross-sectional study investigated the middle- (4 years) to long-term (7 and 10 years) psychological impact of PST for 3 autosomal dominant late-onset diseases: HD, Machado-Joseph disease (DMJ) and familial amyloid polyneuropathy (FAP). Method: The study included 203 subjects: 170 (84%) agreed to make the PST for FAP, 29 (14%) for HD and 4 (2%) for MJD. They were mostly women (58%) and married (67%). It was considered the cutoffs points: 4 years (middle-term) and 7 and 10 years (long-term) indicating the time after receiving the TPS results. Results: women and widows (oldest) presented the highest mean values for almost all BSI dimensions and the highest values correspond to the obsessive compulsive dimension. MJD participants presented the highest mean values. No differences were found concerning the PST test results while participants are still asymptomatic. Psychopathology was only present in symptomatic carriers. Conclusions: The onset of the disease seems to assume the trigger for psychological disturbance, regardless the time that has elapsed since the PST result communication or the individual carrier/non-carrier condition.
引用
下载
收藏
页码:446 / 452
页数:7
相关论文
共 50 条
  • [21] Long-Term Hydromethylthionine Treatment Is Associated with Delayed Clinical Onset and Slowing of Cerebral Atrophy in a Pre-Symptomatic P301S MAPT Mutation Carrier
    Bentham, Peter
    Staff, Roger T.
    Schelter, Bjoern O.
    Shiells, Helen
    Harrington, Charles R.
    Wischik, Claude M.
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (03) : 1017 - 1023
  • [22] Long-term middle ear pressure measurements in inner ear disorders
    Park, Jonas J. -H.
    Luecke, Kerstin
    Luedeke, Inger
    Emmerling, Oliver
    Westhofen, Martin
    ACTA OTO-LARYNGOLOGICA, 2012, 132 (03) : 266 - 270
  • [23] Modeling the short-, middle- and long-term viral load responses for comparing estimated dynamic parameters
    Huang, Yangxin
    BIOMETRICAL JOURNAL, 2007, 49 (03) : 429 - 440
  • [24] Middle- and Long-Term Streamflow Forecasting and Uncertainty Analysis Using Lasso-DBN-Bootstrap Model
    Chu, Haibo
    Wei, Jiahua
    Jiang, Yuan
    WATER RESOURCES MANAGEMENT, 2021, 35 (08) : 2617 - 2632
  • [25] Middle- and Long-Term Streamflow Forecasting and Uncertainty Analysis Using Lasso-DBN-Bootstrap Model
    Haibo Chu
    Jiahua Wei
    Yuan Jiang
    Water Resources Management, 2021, 35 : 2617 - 2632
  • [26] Ethanol from lignocellulosic biomass: techno-economic performance in short-, middle- and long-term
    Hamelinck, CN
    van Hooijdonk, G
    Faaij, APC
    BIOMASS & BIOENERGY, 2005, 28 (04): : 384 - 410
  • [27] Impact of long-term lithium treatment on suicidality in affective disorders
    Hanus, H
    Tuma, I
    HOMEOSTASIS IN HEALTH AND DISEASE, 1996, 37 (05): : 215 - 215
  • [28] PSYCHOPATHOLOGICAL AND SOCIAL-STATUS OF PATIENTS WITH AFFECTIVE, SCHIZOPHRENIC AND SCHIZOAFFECTIVE DISORDERS AFTER LONG-TERM COURSE
    MARNEROS, A
    DEISTER, A
    ROHDE, A
    ACTA PSYCHIATRICA SCANDINAVICA, 1990, 82 (05) : 352 - 358
  • [29] The impact of working memory testing on long-term associative memory
    Xie, Kathy Y.
    Reuter-Lorenz, Patricia A.
    MEMORY & COGNITION, 2024, 52 (7) : 1626 - 1652
  • [30] Long-term symptomatic status of bipolar I vs. bipolar II disorders
    Judd, LL
    Schettler, PJ
    Akiskal, HS
    Maser, J
    Coryell, W
    Solomon, D
    Endicott, J
    Keller, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2003, 6 (02): : 127 - 137